Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Patten

Showing results (81-90 of 86) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 86 results.
Iscience|August 22, 2022
Identification of potent inhibitors of SARS-CoV-2 infection by combined pharmacological evaluation and cellular network prioritizationJ J Patten, Patrick T Keiser, Deisy Morselli-Gysi, et al.
Chemrxiv : the Preprint Server for Chemistry|November 17, 2020
A Multi-Pronged Approach Targeting SARS-CoV-2 Proteins Using Ultra-Large Virtual ScreeningChristoph Gorgulla, Krishna M Padmanabha Das, Kendra E Leigh, et al.
Iscience|January 11, 2021
A multi-pronged approach targeting SARS-CoV-2 proteins using ultra-large virtual screeningChristoph Gorgulla, Krishna M Padmanabha Das, Kendra E Leigh, et al.
Cell Death & Disease|March 25, 2021
Inhibition of HECT E3 ligases as potential therapy for COVID-19Giuseppe Novelli, Jing Liu, Michela Biancolella, et al.
Molecular Cell|January 8, 2021
Actionable Cytopathogenic Host Responses of Human Alveolar Type 2 Cells to SARS-CoV-2Ryan M Hekman, Adam J Hume, Raghuveera Kumar Goel, et al.
Molecular Cell|December 1, 2020
Actionable Cytopathogenic Host Responses of Human Alveolar Type 2 Cells to SARS-CoV-2Ryan M Hekman, Adam J Hume, Raghuveera Kumar Goel, et al.
Pageof 9

Showing results (81-90 of 86) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 86 results.
Iscience|August 22, 2022
Identification of potent inhibitors of SARS-CoV-2 infection by combined pharmacological evaluation and cellular network prioritizationJ J Patten, Patrick T Keiser, Deisy Morselli-Gysi, et al.
Chemrxiv : the Preprint Server for Chemistry|November 17, 2020
A Multi-Pronged Approach Targeting SARS-CoV-2 Proteins Using Ultra-Large Virtual ScreeningChristoph Gorgulla, Krishna M Padmanabha Das, Kendra E Leigh, et al.
Iscience|January 11, 2021
A multi-pronged approach targeting SARS-CoV-2 proteins using ultra-large virtual screeningChristoph Gorgulla, Krishna M Padmanabha Das, Kendra E Leigh, et al.
Cell Death & Disease|March 25, 2021
Inhibition of HECT E3 ligases as potential therapy for COVID-19Giuseppe Novelli, Jing Liu, Michela Biancolella, et al.
Molecular Cell|January 8, 2021
Actionable Cytopathogenic Host Responses of Human Alveolar Type 2 Cells to SARS-CoV-2Ryan M Hekman, Adam J Hume, Raghuveera Kumar Goel, et al.
Molecular Cell|December 1, 2020
Actionable Cytopathogenic Host Responses of Human Alveolar Type 2 Cells to SARS-CoV-2Ryan M Hekman, Adam J Hume, Raghuveera Kumar Goel, et al.
Pageof 9